why choose us

First received: November 18, 2025

Clinical Trial: Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Nausea and Vomiting, Postoperative
Prevention

Study Type: INTERVENTIONAL


Official Title: Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

Brief Summary: Postoperative nausea and vomiting (PONV) are a frequent and debilitating complications after surgery, affecting up to 80% of patients at high risk in the absence of prophylaxis.Despite the rigorous application of the recommendations from the American Society of Anesthesiologists (ASA) at CHUM, a recent local study reveals a prevalence of 25% PONV at home after outpatient surgery. However, the therapeutic options at home remain limited.This study aims to evaluate if the addition of 40 mg aprepitant to a multimodal…

Read more